Related Experiment Video
Updated: May 16, 2026
09:03
Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
Characterization of three newly established rat sarcoma cell clones
Monika Holubova1, Martin Leba, Markéta Sedmikova
1Institute of Animal Physiology and Genetics, AS CR v.v.i., 277 21, Libechov, Czech Republic. holubova@iapg.cas.cz
In Vitro Cellular & Developmental Biology. Animal
|November 15, 2012
Summary
Three distinct rat sarcoma clones (C4, C7, D6) were established for cancer research. Clone C4 demonstrated spontaneous tumor regression in vivo, linked to immune cell changes, offering insights into sarcoma behavior.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Establishing novel animal models is crucial for advancing cancer investigations.
- Selected cell lines with distinct behaviors are vital for creating relevant models.
Purpose of the Study:
- To characterize three novel, morphologically distinct rat sarcoma clones (C4, C7, D6) derived from the R5-28 cell line.
- To evaluate their potential as models for cancer research.
Main Methods:
- Morphological and immunophenotypic characterization of sarcoma clones.
- Assessment of proliferative capacity using proliferating cell nuclear antigen (PCNA) and BrdU.
- Karyotyping to analyze chromosomal abnormalities.
- Quantification of cytokine and chemokine expression.
- In vivo tumor studies including monitoring regression and analyzing lymphocyte subpopulations.
Main Results:
- All clones (C4, C7, D6) expressed vimentin, fibronectin, laminin, collagen IV, MMP-2, and MMP-9, but lacked desmin, cytokeratins 8/18, ZO-1, and desmoplakins.
- Significant proliferative capacity was confirmed by PCNA and BrdU positivity.
- Karyotypes deviated from normal diploid rat cells.
- High expression of monocyte chemoattractant protein 1, tissue inhibitor of metalloproteinases 1, and vascular endothelial growth factor was observed in all clones.
- Variations in neutrophil-associated chemokines (cytokine induced neutrophil chemoattractant 2, lipopolysaccharide induced CXC chemokine) were noted.
- Clone C4 exhibited spontaneous tumor regression in vivo, accompanied by alterations in lymphocyte subpopulations.
Conclusions:
- The characterized rat sarcoma clones (C4, C7, D6) represent distinct cellular models for cancer research.
- Clone C4's spontaneous in vivo regression and associated immune changes provide a unique model for studying tumor dormancy and immune responses in sarcoma.
